Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Ed Overfield shares his personal battle with non-small cell lung cancer, a journey marked by the loss of his mother to the same disease and his own diagnosis…
Rajdeep Mysore, MD discusses melanoma, the most dangerous type of skin cancer. Originating from melanocytes, the color-producing cells in the skin, melanomas often appear as black or brown…
Helen Rizos, PhD focuses on the clinical value of cell-free DNA in the management of melanoma. It highlights how circulating tumor DNA can be predictive and prognostic for…
This video shares the journey of how the pap smear, a crucial test for cervical cancer, became a routine part of healthcare for women. It highlights the diverse…
Most vaccines help the immune system learn to identify and fight off harmful viruses or bacteria before someone gets sick. But, scientists are also creating vaccines to treat…
Angela Belcher, PhD; Sangeeta Bhatia, MD, PhD; and Paula Hammond, PhD, from the Koch Institute at MIT, Cambridge, MA, present multi-dimensional approaches to early detection in ovarian cancer.…
Emma Rossi, MD, a gynecologic oncologist at Duke Health, discusses cervical cancer prevention and HPV. Dr Rossi explains that cervical cancer is the third most common gynecologic cancer…
Dr. Caitlin McMullen and panelists Dr. Kedar Kirtane, Dr. Sarimar Agosto Salgado, and Barb Wampler, RN, discuss new therapies and clinical trial development in head and neck and…
Peter Attia, MD, joins MedCram to discuss the optimization of cancer screening using various techniques, including information on timing, imaging (full body MRI, etc), and liquid biopsies. Dr…
Brad Leibovich, MD, a urologic oncologist at Mayo Clinic, explains that kidney cancer in its early stages often presents no signs or symptoms and there is no screening…
